Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation. (May 2018) - Schmalbrock, Laura; Bonifacio, Lynn; Bill, Marius; Jentzsch, Madlen; Schubert, Karoline; Grimm, Juliane; Cross, Michael; Lange, Thoralf; Vucinic, Vladan; Pönisch, Wolfram; Behre, Gerhard; Franke, Georg-Nikolaus; et al.